Cargando…
Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441338/ http://dx.doi.org/10.1186/1742-4690-9-S2-O8 |
| _version_ | 1782243265652719616 |
|---|---|
| author | Banerjee, K Balsitis, S Jamil, T Jones, C Dey, A Flandez, J Brito, L Cu, Y Beard, C Santra, S Pal, R Miller, N Valiante, NM Mason, P Barnett, SW Otten, GR |
| author_facet | Banerjee, K Balsitis, S Jamil, T Jones, C Dey, A Flandez, J Brito, L Cu, Y Beard, C Santra, S Pal, R Miller, N Valiante, NM Mason, P Barnett, SW Otten, GR |
| author_sort | Banerjee, K |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3441338 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-34413382012-09-18 Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660 Banerjee, K Balsitis, S Jamil, T Jones, C Dey, A Flandez, J Brito, L Cu, Y Beard, C Santra, S Pal, R Miller, N Valiante, NM Mason, P Barnett, SW Otten, GR Retrovirology Oral Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441338/ http://dx.doi.org/10.1186/1742-4690-9-S2-O8 Text en Copyright ©2012 Banerjee et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation Banerjee, K Balsitis, S Jamil, T Jones, C Dey, A Flandez, J Brito, L Cu, Y Beard, C Santra, S Pal, R Miller, N Valiante, NM Mason, P Barnett, SW Otten, GR Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660 |
| title | Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660 |
| title_full | Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660 |
| title_fullStr | Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660 |
| title_full_unstemmed | Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660 |
| title_short | Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660 |
| title_sort | prime-boost regimen potency and efficacy with alphavirus replicons (siv antigen) in non-human primates challenged with low-dose intra-rectal sivsme660 |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441338/ http://dx.doi.org/10.1186/1742-4690-9-S2-O8 |
| work_keys_str_mv | AT banerjeek primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT balsitiss primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT jamilt primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT jonesc primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT deya primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT flandezj primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT britol primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT cuy primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT beardc primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT santras primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT palr primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT millern primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT valiantenm primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT masonp primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT barnettsw primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 AT ottengr primeboostregimenpotencyandefficacywithalphavirusrepliconssivantigeninnonhumanprimateschallengedwithlowdoseintrarectalsivsme660 |